EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment

M Borowczyk, M Kaczmarek-Ryś, S Hryhorowicz, M Sypniewski, D Filipowicz, P Dobosz, M Oszywa, M Ruchała, K Ziemnicka

Journal of Endocrinological Investigation · 2024

DOI: 10.1007/s40618-024-02389-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von M Borowczyk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznan, Pol…. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms, Polymorphism, Single Nucleotide, Nod2 Signaling Adaptor Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Directorate-General for Regional Policy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Differentiated thyroid cancer (DTC) presents a complex clinical challenge, especially in patients with distant metastases and resistance to standard treatments. This study aimed to investigate the influence of specific genes and their germline single nucleotide polymorphisms (SNPs) linked to both inflammatory processes and other neoplasms on the clinical and pathological characteristics of DTC, particularly their potential impact on radioiodine (RAI) treatment efficacy.

Methods

This retrospective analysis involved a cohort of 646 patients diagnosed with DTC after thyroidectomy. Study covering 1998–2014, updated in 2023, included 567 women and 79 men (median age: 49; range: 7–83). SNP selection targeted functional significance, while mutational status was assessed by pyrosequencing for comprehensive characterization. Patient genetic profiles were assessed for associations with disease characteristics, RAI response, and cancer pathology.

Results

Significant correlations emerged between certain SNPs and DTC features. Notably, the NOD2 c.802 T > C variant (rs2066842) was identified as a marker distinguishing between papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC). Moreover, the c.802 T allele was associated with an enhanced response to RAI treatment, indicating a more substantial decrease in posttreatment stimulated thyroglobulin (sTg) concentrations. The NFKB1A allele c.126A (rs696) exhibited connections with lower FTC stages and a reduced probability of multifocality.

Conclusion

This study explored the molecular mechanisms of particular SNPs, highlighting the role of NOD2 in innate immunity and the stress response, and its potential impact on RAI efficacy. This research underscores the clinical promise of SNP analysis and contributes to personalized treatment strategies for DTC, emphasizing the relevance of genetic factors in cancer progression and treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesThyroid NeoplasmsPolymorphism, Single NucleotideNod2 Signaling Adaptor ProteinHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAgedYoung AdultAdolescentAged, 80 and overChildGerm-Line MutationThyroidectomyPrognosisAdenocarcinoma, FollicularTreatment OutcomeBiomarkers, TumorThyroid Cancer, PapillaryFollow-Up Studies

Stichwörter der Autor:innen

Chronic lymphocytic thyroiditisDifferentiated thyroid cancerRadioiodine treatmentSingle nucleotide polymorphismsThyroglobulin

Substanzen

Iodine RadioisotopesNod2 Signaling Adaptor ProteinNOD2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznan, Poland. martyna.borowczyk@gmail.com.
  • Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • University Cancer Diagnostic Center, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznan, Poland.
  • Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland.

Förderung

  • Narodowe Centrum Nauki
  • Directorate-General for Regional Policy

Zitieren

APA

Borowczyk, M., Kaczmarek-Ryś, M., Hryhorowicz, S., Sypniewski, M., Filipowicz, D., Dobosz, P., Oszywa, M., Ruchała, M., & Ziemnicka, K. (2024). Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02389-0

Vancouver

Borowczyk M, Kaczmarek-Ryś M, Hryhorowicz S, Sypniewski M, Filipowicz D, Dobosz P, et al. Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02389-0

BibTeX
@article{Borowczyk2024,
  author = {Borowczyk, M and Kaczmarek-Ryś, M and Hryhorowicz, S and Sypniewski, M and Filipowicz, D and Dobosz, P and Oszywa, M and Ruchała, M and Ziemnicka, K},
  title = {Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  doi = {10.1007/s40618-024-02389-0}
}
Kostenlos starten →